A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

March 31, 2004

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

tiotropium inhalation powder capsule

DRUG

ipratropium bromide Metered Dose Inhaler

Trial Locations (6)

100044

People Hospital of Beijing University, Beijing

100730

Peking Union Medical College Hospital, Beijing

110001

1st Hospital of Chinese Medical University, Shenyang

200032

Zhongshan Hospital of Fudan University, Shanghai

200080

Shanghai 1st People Hospital, Shanghai

510120

1st Hospital of Guangzhou Medical College, Guangzhou

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00239434 - A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter